CN101037475B - 一种嵌合受体及其制备方法和用途 - Google Patents
一种嵌合受体及其制备方法和用途 Download PDFInfo
- Publication number
- CN101037475B CN101037475B CN2006100247033A CN200610024703A CN101037475B CN 101037475 B CN101037475 B CN 101037475B CN 2006100247033 A CN2006100247033 A CN 2006100247033A CN 200610024703 A CN200610024703 A CN 200610024703A CN 101037475 B CN101037475 B CN 101037475B
- Authority
- CN
- China
- Prior art keywords
- cell
- chimerical receptor
- tumour
- cars
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100247033A CN101037475B (zh) | 2006-03-15 | 2006-03-15 | 一种嵌合受体及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100247033A CN101037475B (zh) | 2006-03-15 | 2006-03-15 | 一种嵌合受体及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101037475A CN101037475A (zh) | 2007-09-19 |
CN101037475B true CN101037475B (zh) | 2012-08-15 |
Family
ID=38888673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100247033A Expired - Fee Related CN101037475B (zh) | 2006-03-15 | 2006-03-15 | 一种嵌合受体及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101037475B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201600791TA (en) | 2010-06-08 | 2016-03-30 | Genentech Inc | Cysteine engineered antibodies and conjugates |
CN104072616A (zh) * | 2013-03-29 | 2014-10-01 | 上海中信国健药业股份有限公司 | 一种嵌合受体及其制备方法和用途 |
AU2015314826A1 (en) | 2014-09-12 | 2017-03-02 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
EP3581200A1 (en) * | 2018-06-13 | 2019-12-18 | GEMoaB Monoclonals GmbH | Reversed universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders |
WO2022127889A1 (zh) * | 2020-12-18 | 2022-06-23 | 江苏先声药业有限公司 | Her2抗体及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003042231A2 (de) * | 2001-11-12 | 2003-05-22 | Gundram Jung | Bispezifisches anti-cd28-antikörper-molekül |
-
2006
- 2006-03-15 CN CN2006100247033A patent/CN101037475B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003042231A2 (de) * | 2001-11-12 | 2003-05-22 | Gundram Jung | Bispezifisches anti-cd28-antikörper-molekül |
Non-Patent Citations (1)
Title |
---|
解志刚等.抗人P185erbB2的scFv2Fc 融合蛋白的表达及免疫功能分析.《生物化学与生物物理学报》.2003,第35卷(第4期),371-374. * |
Also Published As
Publication number | Publication date |
---|---|
CN101037475A (zh) | 2007-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110818802B (zh) | 一种嵌合t细胞受体star及其应用 | |
EP3581200A1 (en) | Reversed universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders | |
WO2020063787A1 (zh) | 抗b7-h3的单克隆抗体及其在细胞治疗中的应用 | |
JP6911105B2 (ja) | 抗体重鎖不変部位ヘテロ二量体(heterodimeric Fc)に融合したIL−21(heterodimeric Fc−fused IL−21)及びこれを含む薬剤学的組成物 | |
EP3553091A1 (en) | Gd2-expressing cell | |
CN108093638A (zh) | 经修饰的白细胞介素-7蛋白及其用途 | |
US20200354458A1 (en) | Bifunctional Fusion Protein Targeting CD47 and PD-L1 | |
WO2018145649A1 (zh) | 一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定 | |
CN108064252A (zh) | 嵌合抗原受体及其使用方法 | |
CN105407902A (zh) | 溶瘤病毒 | |
CN108070607A (zh) | 靶向CD19-41BB-tEGFR的嵌合抗原受体及其用途 | |
JP2002521053A (ja) | ヘテロミニ体 | |
CN109385400A (zh) | 共表达pd-l1阻断剂的嵌合抗原受体修饰的免疫效应细胞 | |
JP2022506777A (ja) | がんの処置において使用するための微生物および免疫モジュレーターの併用療法 | |
CN101037475B (zh) | 一种嵌合受体及其制备方法和用途 | |
CN108017717A (zh) | 一种用于体外高效定向扩增的嵌合抗原受体及其应用 | |
CN108395481A (zh) | 一种靶向cd20的car的构建及其工程化t细胞的活性鉴定 | |
CN108070608A (zh) | 靶向CD19-CD28-tEGFR的嵌合抗原受体及其用途 | |
CN113788894A (zh) | 靶向人Claudin18.2蛋白的单克隆抗体及其应用 | |
CN109423495A (zh) | 一种双靶向嵌合抗原受体及其用途 | |
CN102884194B (zh) | 含增强免疫应答的Fc融合蛋白的方法和组合物 | |
CN107936120A (zh) | Cd19靶向性的嵌合抗原受体及其制法和应用 | |
CN109161532A (zh) | 同时靶向psma和pd-l1的工程化免疫细胞 | |
CN109777783A (zh) | 表达cxcr2的car-nk92细胞、制备方法及其应用 | |
CN116514998B (zh) | 一种嵌合抗原受体、嵌合抗原受体-自然杀伤细胞及其在制备抗肿瘤药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080801 Address after: Shanghai Pudong New Area Jing Road No. 351 Building No. 1 room 431 Applicant after: Shanghai Guojian Biological Technology Institute Address before: Bing Shanghai Road, Pudong New Area Zhangjiang hi tech Park No. 399 Applicant before: Zhongxin Guojian Pharmaceutical Co., Ltd., Shanghai |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI CP GUOJIAN PHARMACEUTICAL CO.,LTD. Free format text: FORMER OWNER: SHANGHAI GUOJIAN BIOTECHNOLOGY INSTITUTE Effective date: 20110104 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 ROOM 431, BUILDING 1, NO.351, GUOSHOUJING ROAD, PUDONG NEW DISTRICT,SHANGHAI TO: 201203 NO.399, LIBING ROAD, HIGH-TECH PARK, ZHANGJIANG, PUDONG NEW DISTRICT, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110104 Address after: Shanghai city 201203 libing road Pudong New Area Zhangjiang hi tech Park No. 399 Applicant after: Shanghai CP Guojian Pharmaceutical Co., Ltd. Address before: 201203 Shanghai Pudong New Area Jing Road No. 351 Building No. 1 room 431 Applicant before: Shanghai Guojian Biological Technology Institute |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120815 Termination date: 20130315 |